Shows
pharmaphorum PodcastThe value of a partner, globally and locallyWith the FDA and EMA releasing their annual reports detailing novel drug approvals in 2024, a new pharmaphorum podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face in the year ahead.
Host Nicole Raleigh is joined by Cencora’s Sandra Anderson, SVP of International Commercialisation, and Chris Williams, SVP & International Managing Director at Alloga Europe and ICS, which are part of Cencora – and the conversation dives into takeaways such as the increase in smaller biotech companies taking their product to market on their own, what is n...2025-05-0922 min
pharmaphorum PodcastAI in drug development: The real hurdle is implementationIt can take up to 15 years for a new drug to reach the market, and with only 20% of pharmaceutical professionals adopting AI, one thing is clear: innovation in drug development is lagging behind.
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Andrew Stelzer, head of business development at Unlearn.AI, about how the real hurdle in clinical research lies in effectively integrating AI.
Stelzer discusses the need for greater coordination within the pharmaceutical industry, particularly between life sciences and software engineering and explains how bridging the cultural divide can significantly enhance the...2025-05-0112 min
pharmaphorum PodcastPatients as active consumers of care: AI-driven personalisation in pharma marketingTherapy initiation, adherence, and health outcomes are being driven by artificial intelligence (AI)-powered personalisation. Today’s consumers are more active participants in their healthcare. Marketing in the era of consumer-driven healthcare requires new strategies to reach patients with the information they require, and how and when they need it.
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Bill Grambley, CEO of AllazoHealth, for a conversation on leveraging AI for marketing, as well as medication initiation and adherence.
Grambley discusses how AI can be leveraged to create highly personalised patient engagement strategies, ta...2025-04-2924 min
pharmaphorum PodcastDriving the drug discovery pipeline: The value of organ-on-a-chip MPSIn a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Tomasz Kostriezewski, CSO at CN Bio, about single organ-on-a-chip technology and multi-organ microphysiological systems (MPS), as well as accelerating drug discovery pipelines with these new alternative methodologies (NAMs).
Clinical trial success rates are very low, with up to 95% not succeeding, and a wide range of disease states remains untreated. What NAMs permit is a screening of new drugs, of whatever entity – chemical or biological – to better predict how they will behave when put into a patient, says Kostriezewski.
From metabolic to neurological diseases, as well...2025-04-2218 min
pharmaphorum PodcastIntelligent regulatory compliance and improved patient outcomesAcross the life sciences, Regulatory Affairs (RA) teams and their colleagues in Quality and Safety are stretched beyond their limits as already impossible demands on their time are compounded by rising health authority expectations.
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Sonia A. Veluchamy, CEO and co-founder of Celegence, a company dedicated to improving patient outcomes through intelligent regulatory compliance.
For both pharma and medical device companies, time and bandwidth are the number one challenge RA professionals face, closely followed by costs and budgetary pressures (the latter being a more pronounced...2025-04-1615 min
pharmaphorum PodcastPrevention for a healthier, more productive societyIn a new pharmaphorum podcast, recorded during Anthropy 2025: Rebooting Britain, web editor Nicole Raleigh spoke with David Gillen, chief medical officer at Norgine, about the role of prevention in the future of healthcare.
Recorded onsite at The Eden Project in Cornwall, the conversation centred around the Adelphi Group-sponsored panel, ‘The Prevention Revolution in Your Healthcare’, exploring the key takeaways and exciting possibilities from the panel discussion.
Prevention is increasingly seen as contributing to a healthier and more productive society. But, as healthcare resources are stretched and medical science is accelerating, the question remains: how do we m...2025-04-1515 min
pharmaphorum PodcastSafeguarding the pharmaceutical supply chainAs we hear of the volcanic and seismic activity taking place in Iceland this week, pharmaphorum turns back to a conversation with Dean Alms, CPO of Aravo, on how extreme weather highlights the need to make adequate supply chain preparations for the seasons in which the planet pulls out all the stops with the worst of its natural disasters.
Having a blueprint for supply chain resiliency is critical, as a mature and robust risk programme enables the right emergency protocols and drug reserves to be in place in the worst-case scenarios, and permits plants to return to...2025-04-0213 min
pharmaphorum PodcastGenAI and the revolution of drug developmentIt takes around seven years to develop a new drug and bring it to market. With the advent of GenAI, businesses in the life sciences sector can speed up the process, wiping months or even years off that average.
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Bryan Hill, life sciences chief technology officer at Cognizant, in a conversation on how generative AI is revolutionising life sciences and drug development.
Though it might seem an obvious path, not all life sciences companies are jumping on the bandwagon to adopt GenAI. Instead, many...2025-03-0511 min
pharmaphorum PodcastPatient-focused manufacturing models for personalised therapiesUnique, patient-focused manufacturing models are needed to scale up innovative cell therapies for cancer and one company, CTMC, is challenging the status quo to achieve this and get them to patients.
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Jason Bock, co-founder and CEO of CTMC, a first-of-its-kind cell therapy engine aiming to advance novel scientific breakthroughs into medicines developed rapidly and robustly to - ultimately - end cancer.
Taking learnings from the monoclonal antibody field to come up with a fit-for-purpose solution, Bock discusses his work in the joint venture between t...2025-02-2822 min
pharmaphorum PodcastPaediatric rare diseases: Children are not small adultsAround 75% of rare diseases are diagnosed in childhood, with most before the age of two. With 30% of rare disease patients dying before the age of five, the need for different treatment methods for children is clear.
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Helen Thackray, chief R&D officer at biotech company BioCryst, as well as an alumnus of the Children’s National Medical Center.
The conversation touches upon incentivisation for manufacturers to develop drugs to treat rare diseases, addressing age-appropriate formulations and recognising the metabolic differences between children and ad...2025-02-2016 min
pharmaphorum PodcastDefining, building, and implementing in the next wave of biopharma R&DIn a new pharmaphorum podcast, web editor Nicole Raleigh speaks with two PharmaLex experts about navigating complex R&D processes to unleash the next wave of biopharma breakthroughs.
PharmaLex’s Dr Christian Schneider, VP & Chief Medical Officer, Clinical Development Services, together with Dr Christelle Boileau, Director of Regulatory Development Strategy and IPD solution lead at PharmaLex, which is part of Cencora, explore the many challenges faced across the clinical trial landscape when it comes to new therapies, including ATMP development.
From preclinical to market access and regulatory considerations, Dr Boileau warns that development is not a...2025-02-1325 min
pharmaphorum PodcastInsights from JP Morgan Healthcare 2025: Key trends shaping the pharma industryThe JP Morgan Healthcare Conference remains one of the most influential events for the life sciences sector, setting the stage for major deal-making, investment trends, and strategic shifts that will define the year ahead.
Keen to capture all the key trends and talking points from this year’s event, pharmaphorum editor-in-chief, Jonah Comstock, hit the ground running in Philadelphia, live blogging key sessions and interviewing experts to find out what industry insiders foresee for 2025.
In this special extended episode of the pharmaphorum podcast, Jonah sits down with Deep Dive editor, Eloise McLennan, to break down the key...2025-02-061h 04
pharmaphorum Podcast‘Show me the molecule’ – On synthetic biology and cutting through AI hypeTherapeutic antibodies are a vital weapon in combating diseases such as cancer, but developing these treatments through conventional methods is slow and unreliable.
In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Dr James Field, founder and CEO of LabGenius, a drug discovery company pioneering the discovery of next-generation therapeutic antibodies in order to solve this predicament.
Dr Field speaks to how can industry cut through the hype that surrounds AI and optimally assess the technical underpinnings of an AI proposition in medicine. He describes how LabGenius overcomes the so-called “cognition barrier” by usin...2025-02-0415 min
pharmaphorum PodcastSimulated clinical trial populations and AI scalabilityAI might still be in the modish buzzword stage, but discussions exploring the potential for its scaling within life sciences are critical.
In a new pharmaphorum podcast with ZS Associates’ Sharon Karlsberg, principal and leader of oncology solutions, and Brandi Davis-Dusenbery, principal and partner, web editor Nicole Raleigh explores the potential for scaling advanced technologies in the biopharmaceutical industry.
From digital twins and insilico modelling and the potential to reduce experimentation in human populations with simulated populations and differently designed trials, to document authoring and automation for time-saving purposes – the conversation on leveraging AI turns also...2025-01-3029 min
pharmaphorum PodcastRare disease and the women's health gapFor women with rare diseases, they often face a double jeopardy, where many of the symptoms they experience can be confused with and misdiagnosed as menopause.
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Jennifer Schranz, head of rare diseases at Ipsen, for a conversation focused on rare liver disease primary biliary cholangitis (PBC), which affects nine women for every one man, and the women’s health gap more generally.
Schranz explains the importance of developing a more individualised approach to management and treatment of PBC for each patient and discusses Ipsen’s PB...2025-01-2315 min
pharmaphorum PodcastFrom science fiction to reality: AI in drug developmentWith about 92% of new drugs failing in human clinical trials, pharma companies face tremendous financial losses and, more importantly, development and delivery of potentially life-saving treatments are woefully delayed.
In today’s pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Isaac Bentwich, CEO and founder of Quris.AI, about how AI could revolutionise preclinical research and accelerate the development of potentially life-saving drugs, safely.
Exploring the notion of 3D organ modelling, combining AI and ‘advanced’ biology such as organ-on-chip, and delving into his research passion of the rare diseases space, including FragileX, Bentwich explains that t...2025-01-1521 min
pharmaphorum PodcastPrecision medicine, NGS, and the quantum leap in biomarkersIn a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of Medical and Scientific Affairs at Thermo Fisher Scientific, a company committed to advancing precision medicine, for a conversation on this space and a new frontier of biomarkers.
Quagliata discusses Thermo Fisher’s ongoing collaboration with EVERSANA, pharmaphorum’s parent company, and that collaboration’s investigation of the impact of utilising electronic health record (EHR) data in haematological cancers to support the company’s value proposition for ultra-fast next generation sequencing (NGS) with oncomine myeloid solutions.
That included...2024-12-1823 min
pharmaphorum PodcastInvestment outlook: Key takeaways from LSX USAInvestment and strategic partnerships are the lifeblood of innovation in healthcare, driving groundbreaking discoveries and accelerating the development of life-changing therapies. And so, it was no surprise that the 2024 LSX USA Congress in Boston attracted life sciences innovators and decision-makers from around the world, eager to explore the latest trends shaping the industry.
Among those attendees was pharmaphorum’s editor-in-chief, Jonah Comstock, who took to the floor to uncover the trends and talking points set to influence investment decisions in the coming months.
In this special episode of the pharmaphorum podcast, Jonah sat down with De...2024-10-0433 min
pharmaphorum PodcastOncology today: Eversana and pharmaphorum at ESMO 2024The ESMO congress always disseminates the latest results of cancer research, a vibrant gathering and sharing of the latest data, communicating the next promising steps in oncological scientific development, ever seeking to address unmet patient needs.
So it was that pharmaphorum Web Editor Nicole Raleigh found a quiet spot onsite in Barcelona this year to catch with experts from EVERSANA and discuss their takeaways from the 2024 conference. Tune in to hear more from: Ann Marie Robertson, Chief Commercial Officer, EVP, EVERSANA COMPLETE Oncology, EVERSANA; Barry Vucsko, Senior Vice President, Client Services and Business Development Leader, EVERSANA INTOUCH...2024-09-2518 min
pharmaphorum PodcastHeadlines and hot topics from ASCO and BIOThis week, pharmaphorum editor-in-chief Jonah Comstock headed to not one but two back-to-back events in the US. Starting with the American Society of Clinical Oncology’s (ASCO) annual conference in Chicago, before hitting the floor at the BIO International Convention in Boston, there was plenty of innovation, news, and expert knowledge on display.
Fresh from the floor of BIO International, Jonah sat down with pharmaphorum Deep Dive editor Eloise McLennan to reflect on the biggest topics and trends from each event – and the impact these developments may have on pharma over the coming months.
2023-06-0943 min
pharmaphorum PodcastKey themes from JP Morgan, with Paul Tunnahpharmaphorum Editor-in-Chief Jonah Comstock and pharmaphorum Founder Paul Tunnah headed to San Francisco this week for the JP Morgan conference, the annual elbow-rubbing opportunity for biotech bigwigs. This is the first time the show has been back in person since COVID, and, despite some less than ideal weather, attendees were excited to resume in person collaboration.
2023-01-1220 min
pharmaphorum PodcastWhat we heard and saw at HLTH22, with Matthew Holtpharmaphorum Editor-in-Chief Jonah Comstock traveled to Las Vegas last week with thousands of other healthcare stakeholders for the HLTH 2022 conference.
In this post-show edition of the pharmaphorum podcast, Jonah welcomes Matthew Holt, editor of The Healthcare Blog and former digital health event organiser, to discuss the show itself and the content therein.
2022-11-2448 min
pharmaphorum PodcastDisrupting the standard of healthcare for BangladeshIn this mini episode of the pharmaphorum podcast, web editor Nicole Raleigh spoke with Sylvana Sinha, founder, chair, and CEO of Praava Health, Bangladesh’s fastest growing healthcare brand.
2022-11-1810 min
pharmaphorum PodcastHow immersive audio can be a therapeutic toolIn this episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock chats with Howard Rose, head of health and wellness at Spatial about immersive audio: what it is, how it works, and how it can help in healthcare.
2022-11-1729 min
pharmaphorum PodcastA new hope in cachexia and an outsider’s view on pharmaIn the latest installment of the pharmaphorum podcast, Editor in Chief Jonah Comstock sits down with Russell Potterfield, CEO at Endevica Pharma.
A biotech CEO who comes from the business and investment worlds, Russell now runs Endevica, which is working on a novel therapy for cachexia, a wasting syndrome that accompanies many cancers.
2022-11-1020 min
pharmaphorum PodcastWhy is digital health so challenging for big tech?In this episode of the pharmaphorum podcast, host Jonah Comstock taps XIL Health’s Susan Lang to better understand why big tech’s ventures into healthcare seem to stumble more often than not.
2022-11-0327 min
pharmaphorum PodcastLive from Frontiers Health 2022 - the pharmaphorum podcastIn this special, live edition of the pharmaphorum podcast, recorded at the conclusion of Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock and pharmaphorum Web Editor Nicole Raleigh are joined by author, consultant, and podcast host Tony Estrella and Healthware Labs Managing Director Kristin Milburn to discuss their key takeaways from the show last week in Milan.
2022-10-2729 min
pharmaphorum PodcastLive from Reuters Pharma 2022 - the pharmaphorum podcastIn mid-October, our Web Editor Nicole Raleigh and Deep Dive Editor Eloise McLellan traveled to Nice for the Reuters Pharma event.
This special episode includes a conversation recorded on-site with Nicole, Eloise, Virtual Science AI CEO Thomas Hughes, and VSAI VP of global patient affairs Geraldine Reilly.
And stay tuned for the second half of the episode, where Nicole speaks with Sabine Hutchison, CEO and co-founder of Seuss+, about the Dutch consulting firm’s work with smaller life science companies.
2022-10-2037 min
pharmaphorum PodcastBuilding agile partner relationships at a vaccine-focused biotechIn this episode of the pharmaphorum, Dr Paul Tunnah chats with Jeff Baxter, CEO of VBI Vaccines and Lee Taurman, executive vice president full service commercial at Syneos Health.
2022-10-1346 min
pharmaphorum PodcastUnderstanding the tumour micro-environment – the pharmaphorum podcastDr Marie-Louise Fjällskog, chief medical officer at Faron Pharmaceuticals, joins host Jonah Comstock for the pharmaphorum podcast this week to give us a primer on the tumour micro-environment, what it is, how we understand it, and what it means for the future of cancer care.
2022-10-0620 min
pharmaphorum PodcastHow a once-weekly insulin could disrupt diabetes managementIn the latest pharmaphorum podcast, Florian Baeres, Corporate Vice President for global medical affairs at Novo Nordisk, joins editor in chief Jonah Comstock to talk about the innovative once-weekly insulin currently in development and how it could change the game for people currently managing their type 2 diabetes with daily injections.
2022-09-2216 min
pharmaphorum PodcastHow these parents of a child with a rare disease are making precision medicine work for themIn today’s pharmaphorum podcast, editor in chief Jonah Comstock invites Drs Zachary and Geri Landman to tell their daughter Lucy’s story and the story of their new nonprofit Moonshots for Unicorns, which sets up a framework for parents in their circumstance to directly crowdfund research for rare single-gene disorders – starting with PGAP3.
2022-09-0831 min
pharmaphorum PodcastAI-derived cancer vaccinesToday on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science officer respectively of Transgene, to discuss cancer vaccines in general and Transgene’s recent work in the space in particular.
2022-08-2519 min
pharmaphorum PodcastChallenges and opportunities in the off-patent sectorIn the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Rebecca Guntern, vice president of medicines for Europe at Sandoz.
Rebecca speaks about generics and biosimilars: what they are, why they’re important for medication access and healthcare cost sustainability, and what Sandoz has learned about succeeding in the off-patent world. She also touches on the patient stories behind the headlines and the effect of COVID-19 on the generics market.
2022-08-1124 min
pharmaphorum PodcastBuilding a digital therapeutic for paediatric behavioural health opioidsOn the latest instalment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Dr Benny Alouf, chief medical officer at Limbix to discuss his company’s digital therapeutic for teen depression.
2022-07-2821 min
pharmaphorum PodcastGene silencing and mRNA: breakthroughs and barriersOn this week’s pharmaphorum podcast, editor in chief Jonah Comstock catches up with Dr. Marie Wikström Lindholm, SVP of molecular design at Silence Therapeutics.
2022-07-1422 min
pharmaphorum PodcastRethinking pharmaceutical pain management beyond opioidsOn the latest installment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Tony Mack, CEO at Virpax Pharmaceuticals, in the virtual studio.
2022-07-0521 min
pharmaphorum PodcastWhy diverse clinical trials matterIn this episode of the pharmaphorum podcast, editor in chief Jonah Comstock welcomes Dr. Jennifer Jones-McMeans, divisional vice president for global affairs for Abbott’s vascular business to discuss diversity and equity in clinical trials.
2022-06-1627 min
pharmaphorum PodcastWhere pharma stands on patient centricity, engagement, and trustIn the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock catches up with Pervaise Khan, Managing Director of Life Sciences, UK and Ireland, Accenture.
2022-06-0627 min
pharmaphorum PodcastHow pharma can spur innovation and promote health equity in mental healthIn the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Mohammed Issa, Vice President of Commercial at US Janssen Neuroscience.
2022-05-1925 min
pharmaphorum PodcastInnovative solutions to the drug pricing crisis: the pharmaphorum podcastIn the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Dr Colin Banas, chief medical officer at DrFirst.
They discuss out of control drug pricing, especially in the United States, that has led to nonadherence and care rationing
2022-04-2923 min
pharmaphorum PodcastBig data and how it can change the game in pharma: the pharmaphorum podcastIn the latest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Miruna Sasu, chief strategy officer of COTA and long-time pharma vet - before joining COTA last year, she headed up J&J’s Clinical Trial Feasibility and Advanced Analytics Team and led the Digital Health and Innovation Team at Bristol Myers Squibb.
2022-03-2330 min
pharmaphorum PodcastThe year ahead in digital health and life sciences: the pharmaphorum podcastIn the latest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Jennifer Goldsack, CEO of the Digital Medicine Society (DiMe).
Tune in to hear about the year ahead in digital health and life sciences, as well as the need for partnership and collaboration more broadly between the pharma and tech worlds. Goldsack reports on what she heard in the virtual events surrounding JP Morgan this year, and then puts some of those insights into context out of her own experience.
2022-02-1026 min
pharmaphorum PodcastThe evolution of clinical trials: the pharmaphorum podcastIn the latest episode of the pharmaphorum podcast, Dr Paul Tunnah speaks to head of Patient Engagement at Syneos Health, Marie Emms, and Elligo Health Research vice president, strategic partnerships, Keith Fern.
Together they discuss the changing nature of clinical trials how COVID-19 impacted the sector, and the role technology is playing in supporting trial enrolment and retention.
2022-01-1443 min
pharmaphorum PodcastPatient engagement processes: the pharmaphorum podcastThis episode of the pharmaphorum podcast is the second in a limited series focused on patient engagement that’s being led clinician, consultant and patient advocate, Mark Duman.
2021-12-1740 min
pharmaphorum PodcastMerck on trends in oncology: the pharmaphorum podcastEpisode 45 of the pharmaphorum podcast heard from Dr Stuart Hill, how he’s seen the oncology landscape change and which of those he sees holding the most potential to improve patient outcomes.
2021-11-1217 min
pharmaphorum PodcastSandoz’s Pierre Bourdage on biosimilars: the pharmaphorum podcastIn the latest episode of the podcast Dominic Tyer speaks with Pierre Bourdage, who’s global head of biopharmaceuticals at Sandoz about the big issues in biosimilars.
2021-11-0519 min
pharmaphorum PodcastPatient engagement strategies: the pharmaphorum podcastThis episode of the pharmaphorum podcast is the first in an occasional series focused on patient engagement that’s being led by Mark Duman, a clinician, consultant and patient advocate.
2021-10-2934 min
pharmaphorum PodcastBMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcastEpisode 42 of the pharmaphorum podcast heard from Catherine Owen, who’s senior vice president of major markets at Bristol Myers Squibb, about the future of pharma commercialisation and communications.
2021-10-1525 min
pharmaphorum PodcastNovartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcastEpisode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply chains and how he and his team mitigated disruption to Novartis’ own operations.
2021-10-0424 min
pharmaphorum PodcastVirtual engagement and collaborations: the pharmaphorum podcastAs the world passes the year and a half mark of the COVID-19 pandemic, the evolving experience of the ‘new normal’ environment across the healthcare sector has brought huge changes to the way pharma engages healthcare professionals.
2021-09-2228 min
pharmaphorum PodcastVertex senior country manager Nicola Massey: the pharmaphorum podcastIn the latest episode of the podcast Dominic Tyer speaks with Nicola Massey, who’s Vertex’s senior country manager in the UK and Ireland.
2021-08-2323 min
pharmaphorum PodcastRegenerative medicine and COVID: the pharmaphorum podcastIn the latest episode of the podcast Dominic Tyer speaks with Dr Maria Ines ‘Mari’ Mitrani, chief science officer at the clinical-stage biopharmaceutical company Organicell Regenerative Medicine.
2021-08-1314 min
pharmaphorum PodcastPharmacy and clinical research: the pharmaphorum podcastIn the latest episode of the pharmaphorum podcast, pharmaphorum’s web editor Catherine Longworth speaks to Gerald Finken, the founder and CEO of RxE2.
The US-based company was founded in 2019 and is on a mission to bring the practice of pharmacy into clinical research.
2021-06-3035 min
pharmaphorum PodcastPharma’s post-COVID prospects: the pharmaphorum podcastIn this latest podcast, pharmaphorum spoke to Andrew Meade, life sciences lead UK and Ireland at Accenture, about the trends that emerged in this year’s Q1 results season.
2021-05-2814 min
pharmaphorum PodcastGalapagos UK’s Michael Smyth on COVID and RNA-based tech: the pharmaphorum podcastEpisode 35 of the pharmaphorum podcast heard from Michael Smyth about Galapagos UK and joining the company as medical director just as COVID-19 hit.
2021-04-3017 min
pharmaphorum PodcastBig data and cell therapy development: the pharmaphorum podcastIn the latest episode of the podcast pharmaphorum’s website editor Catherine Longworth speaks with Dr. Darrin Disley, CEO of UK biotech Mogrify
2021-04-201h 01
pharmaphorum PodcastGSK on COVID and vaccine development: the pharmaphorum podcastIn the latest episode of the podcast Dominic Tyer speaks with GlaxoSmithKline’s Philip Cruz about the discovery and commercialisation of new vaccines in the light of the pandemic.
2021-03-3119 min
pharmaphorum PodcastThe meaning of digital innovation: the pharmaphorum podcastThis instalment of the podcast considers the meaning of digital innovation, both in pharma and outside the industry, and features digital transformation leader Edwin Erckens.
2021-03-2324 min
pharmaphorum PodcastNew ways to treat COVID: the pharmaphorum podcastIn episode 31 of the pharmaphorum podcast, Deep Dive editor George Underwood speaks to RedHill biopharma’s chief business officer Guy Goldberg about the potential for new COVID-19 therapeutics to help fight the pandemic and treat patients in the years to come.
2021-03-1219 min
pharmaphorum PodcastRoche on COVID healthcare and testing: the pharmaphorum podcastFor episode 30 I spoke with Dr Ashton Harper, who’s head of medical affairs in the UK and Ireland at Roche Diagnostics, about the pressure COVID-19 has put on healthcare systems.
A former NHS doctor, he noted how stressful and draining some days can be when working at healthcare’s frontline - even in normal times, and that the current fight against the pandemic brings little respite to staff.
2021-02-2619 min
pharmaphorum PodcastRichard Francis discusses his new role as Purespring’s CEO: pharmaphorum podcastIn this episode of the pharmaphorum podcast, our news editor Richard Staines talks to Richard Francis, who took over as CEO of gene therapy company Purespring Therapeutics earlier this month.
Francis was previously CEO of Sandoz, Novartis’ generics and biosimilars division, where he led the development of biosimilars and also sat on the Swiss pharma company’s executive committee.
2021-02-1214 min
pharmaphorum PodcastAstraZeneca’s Rebekah Martin on diversity and inclusion: the pharmaphorum podcastThe theme for episode 28 of the pharmaphorum podcast is diversity and inclusion in pharma, ably addressed by AstraZeneca’s Rebekah Martin.
Serving as senior vice president of reward and inclusion at AstraZeneca, Rebekah discussed how the pharmaceutical industry approaches the promotion of diversity.
In an episode that was recorded in December 2020, she also talked about what inclusion and diversity mean to her company.
2021-01-2924 min
pharmaphorum PodcastJ&J and medical device innovation: the pharmaphorum podcastIn episode 27 of the pharmaphorum podcast I’m joined by Erin McEachren, who’s EU Regional Vice President at J&J Surgical Vision.
She talks about her priorities at J&J, having joined the company six months ago, the current state of the medical devices sector and some of the trends she’s keeping a close eye on.
2020-12-2116 min
pharmaphorum PodcastBiotech trends in COVID era: the pharmaphorum podcastIn episode 26 the pharmaphorum podcast hears from David Solomon, a 30-year life sciences industry veteran who recently took up the position of CEO at the Paris-based biopharmaceutical company Pharnext.
2020-11-3017 min
pharmaphorum PodcastGSK and eosinophil research: the pharmaphorum podcastGlaxoSmithKline’s Nucala (mepolizumab) last month became the first and only biologic treatment approved in the US for Hypereosinophilic Syndrome (HES).
It’s part of the company’s focus on eosinophil-driven diseases and ahead of that regulatory milestone I spoke with Tiffany Robinson-Smith, who’s global medical affairs lead for biologics at GSK, about eosinophils and why they’re an important element of her company’s research programmes.
2020-10-3013 min
pharmaphorum PodcastGitte Aabo on telemedicine and her time at LEO Pharma: the pharmaphorum podcastIn this episode of the podcast Gitte discusses telemedicine, GN Hearing’s work in this area – and the impact of COVID-19, plus her time at LEO Pharma.
2020-09-2816 min
pharmaphorum PodcastThe Alderley Park Discovery Podcast: COVID testing and the Lighthouse LabThe Alderley Park Discovery Podcast, produced in partnership with pharmaphorum, presents perspectives on UK and global bioscience innovation trends, with input from key experts including managing director and leader of Bruntwood SciTech’s Alderley Park Dr Kath Mackay.
2020-09-1522 min
pharmaphorum PodcastAlnylam, gene-silencing and biotech in 2020: the pharmaphorum podcastAnlnylam’s Brendan Martin joined the pharmaphorum podcast for episode 23 to talk about his company’s work in gene-silencing and how it could offer a route to target the current coronavirus pandemic.
2020-08-2719 min
pharmaphorum PodcastNovartis, company culture and COVID-19: the pharmaphorum podcastNovartis’ Steven Baert joined the pharmaphorum podcast for episode 22 to discuss how COVID-19 will change the face2020-07-3000 minpharmaphorum PodcastNovartis, company culture and COVID-19: the pharmaphorum podcastNovartis’ Steven Baert joined the pharmaphorum podcast for episode 22 to discuss how COVID-19 will change the face2020-07-3020 min
pharmaphorum PodcastAmgen and science education: the pharmaphorum podcastHarvard University launched LabXchange in January and the free science education platform has acquired new resonance during the2020-06-3022 minpharmaphorum PodcastAmgen and science education: the pharmaphorum podcastHarvard University launched LabXchange in January and the free science education platform has acquired new resonance during the2020-06-3000 min
pharmaphorum PodcastUK pharma leadership and COVID-19: the pharmaphorum podcastThe COVID-19 pandemic has forced significant changes on the pharmaceutical industry as companies scramble to protect employees, ensure2020-05-2921 minpharmaphorum PodcastUK pharma leadership and COVID-19: the pharmaphorum podcastThe COVID-19 pandemic has forced significant changes on the pharmaceutical industry as companies scramble to protect employees, ensure2020-05-2900 min
pharmaphorum PodcastEisai and Alexa skills in epilepsy: the pharmaphorum podcastVoice technology like Amazon’s Alexa is taking some big steps forward in healthcare and in the pharmaceutical world2020-04-0214 minpharmaphorum PodcastEisai and Alexa skills in epilepsy: the pharmaphorum podcastVoice technology like Amazon’s Alexa is taking some big steps forward in healthcare and in the pharmaceutical world2020-04-0200 min
pharmaphorum PodcastDigital health and interoperability: the pharmaphorum podcastOne of the biggest barriers to applying precision medicine to clinical trials and patient engagement is getting different2020-03-0920 minpharmaphorum PodcastDigital health and interoperability: the pharmaphorum podcastOne of the biggest barriers to applying precision medicine to clinical trials and patient engagement is getting different2020-03-0900 min
pharmaphorum PodcastRoche, big data and patient outcomes: the pharmaphorum podcastIn the first pharmaphorum podcast of 2020 Roche’s Conor Megaw talks about his company’s approach to big data2020-01-0831 minpharmaphorum PodcastRoche, big data and patient outcomes: the pharmaphorum podcastIn the first pharmaphorum podcast of 2020 Roche’s Conor Megaw talks about his company’s approach to big data2020-01-0800 min
pharmaphorum PodcastPfizer and the UK cancer landscape: the pharmaphorum podcastPfizer’s Dr Olivia Ashman joined me for episode 16 of the pharmaphorum podcast, which focuses on the UK2019-12-1128 minpharmaphorum PodcastPfizer and the UK cancer landscape: the pharmaphorum podcastPfizer’s Dr Olivia Ashman joined me for episode 16 of the pharmaphorum podcast, which focuses on the UK2019-12-1100 min
pharmaphorum PodcastLife sciences leadership: the pharmaphorum podcastEpisode 15 of the pharmaphorum podcast marked a return visit for leading life sciences industry authority Professor Brian2019-11-1442 minpharmaphorum PodcastLife sciences leadership: the pharmaphorum podcastEpisode 15 of the pharmaphorum podcast marked a return visit for leading life sciences industry authority Professor Brian2019-11-1400 min
pharmaphorum PodcastAstraZeneca and lung cancer: the pharmaphorum podcastThis episode of the pharmaphorum podcast focuses on lung cancer, with AstraZeneca’s VP, Global Franchise Head, Tagrisso TDR2019-08-0721 minpharmaphorum PodcastAstraZeneca and lung cancer: the pharmaphorum podcastThis episode of the pharmaphorum podcast focuses on lung cancer, with AstraZeneca’s VP, Global Franchise Head, Tagrisso TDR2019-08-0700 min
pharmaphorum PodcastLung cancer’s patient information gap: the pharmaphorum podcastFor episode 13 of the pharmaphorum podcast I went to AstraZeneca’s London base to meet Paul Naish, who’s2019-08-0600 minpharmaphorum PodcastLung cancer’s patient information gap: the pharmaphorum podcastFor episode 13 of the pharmaphorum podcast I went to AstraZeneca’s London base to meet Paul Naish, who’s2019-08-0626 min
pharmaphorum PodcastThe state of UK drug discovery: the pharmaphorum podcastThe UK environment for drug discovery, the impact of artificial intelligence (AI) on medicines research and the role of complex cell models were all on the agenda for episode 12 of the pharmaphorum podcast.
On it I spoke with Chris Molloy, who’s CEO at the UK’s Medicines Discovery Catapult, about the Catapult’s State of the Discovery Nation publication, a joint report with the UK’s biotech trade body the BioIndustry Association.
2019-07-1932 min
pharmaphorum PodcastAddressing global health challenges: the pharmaphorum podcastFor episode 11 of the pharmaphorum podcast our CEO and founder Dr Paul Tunnah took the helm to record a special roundtable episode in Philadelphia with the International AIDS Vaccine Initiative (IAVI).
2019-06-1959 min
pharmaphorum PodcastGene therapy and market access: the pharmaphorum podcastFor episode 10 of the pharmaphorum podcast I spoke to Nicola Redfern, who’s general manager at bluebird bio in the UK.
The Cambridge, Massachusetts-based company has gone from being a gene therapy start-up to having three potential blockbusters on its books, with a CAR-T cancer medicine and potential treatments for a type of sickle-cell disease and a rare and deadly genetic brain disease.
2019-05-3120 min
pharmaphorum PodcastAMR research and Matoke Pharma: the pharmaphorum podcastRe-engineered honey has proved to be a novel and successful development for Matoke Pharma, as well as a crucial step on the UK biotech company’s plans to target antimicrobial resistance (AMR).
In episode 9 of the pharmaphorum podcast Alan Westwood explains the research behind Matoke’s SurgihoneyRO, an antimicrobial wound gel that has a CE mark in Europe, and how the company is taking that product’s reactive oxygen (RO) component to develop novel pharmaceutical antimicrobials.
2019-05-1324 min
pharmaphorum PodcastGSK and digital disruption: the pharmaphorum podcastDigital innovation and disruption in healthcare are the subject of this episode of the pharmaphorum podcast, for which I visited GlaxoSmithKline at their Stockley Park base to speak with Kai Gait, a senior global digital strategy director at the company.
2019-04-0528 min
pharmaphorum PodcastIpsen on neurotoxin research: the pharmaphorum podcastFor episode 7 of the pharmaphorum podcast I spoke to Ipsen’s Philippe Picaut about neurotoxin research, with a particular focus on Botulinum neurotoxins.
2019-03-2811 min
pharmaphorum PodcastSuccessful medical marketing teams: the pharmaphorum podcastThe pharmaphorum podcast’s first episode of 2019 features Professor Brian D Smith on what makes a modern, and successful, medical marketing team.
2019-02-2225 minpharmaphorum PodcastBiotech strategy and nanomedicine: the pharmaphorum podcastFor episode 5 of the pharmaphorum podcast Dominic Tyer met Blueberry Therapeutics’ CEO Dr John Ridden at The Wellcome Collection in London to talk about the UK biotech he co-founded, its strategy and bringing innovation to life through Blueberry’s nanomedicine approach.
2018-12-2120 minpharmaphorum PodcastCommercialising orphan drugs: the pharmaphorum podcastIn episode 4 of the podcast pharmaphorum talked to Dr Joe Wiley, CEO of UK-based biopharmaceutical company Amryt Pharma, about its strategy and work in the rare diseases and gene therapy space.
2018-11-2017 minpharmaphorum PodcastThe future biosimilar landscape: the pharmaphorum podcastFor episode 3 of the pharmaphorum podcast Dominic Tyer went to the UK headquarters of Sandoz to meet the head of the company’s UK specialty business Kavya Gopal.
2018-10-1641 minpharmaphorum PodcastNimble consumer healthcare innovation: the pharmaphorum podcastIn episode 2 of the podcast pharmaphorum talked to the CEO of Infirst Healthcare Manfred Scheske about how he’s seen the consumer health sector develop.
2018-09-1431 min